Mixed Results With Fecal Transplant to Stimulate Cancer Immunotherapy Response
(MedPage Today) -- Fecal microbiome transplant (FMT) produced mixed results for stimulating response to immunotherapy in advanced melanoma, according to two preliminary studies.
In one trial, a donor FMT plus a PD-1 inhibitor led to objective...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news
More News: Cancer | Cancer & Oncology | Dermatology | Immunotherapy | Melanoma | Skin | Skin Cancer | Study | Transplants